|
gptkbp:instanceOf
|
gptkb:drug
gptkb:prostaglandin_analogue
|
|
gptkbp:approvalYear
|
1996
|
|
gptkbp:approvedBy
|
gptkb:FDA
|
|
gptkbp:ATCCode
|
S01EE01
|
|
gptkbp:brand
|
gptkb:Xalatan
|
|
gptkbp:CASNumber
|
130209-82-4
|
|
gptkbp:chemicalFormula
|
C26H40O5
|
|
gptkbp:contraindication
|
hypersensitivity to latanoprost
|
|
gptkbp:developedBy
|
gptkb:Pharmacia
|
|
gptkbp:drugClass
|
antiglaucoma agent
|
|
gptkbp:eliminationHalfLife
|
17 minutes (plasma)
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:form
|
gptkb:eye_drops
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
increases uveoscleral outflow
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:routeOfAdministration
|
ophthalmic
|
|
gptkbp:sideEffect
|
eye irritation
eye redness
eyelash growth
iris pigmentation
|
|
gptkbp:synonym
|
isopropyl unoprostone
latanoprostum
|
|
gptkbp:usedFor
|
gptkb:glaucoma
ocular hypertension
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
included
|
|
gptkbp:bfsParent
|
gptkb:Rocklatan
gptkb:Xelpros
gptkb:Xalatan
|
|
gptkbp:bfsLayer
|
8
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
latanoprost
|